Treatment of systemic lupus erythematosus with mycophenolate mofetil.

Abstract	Mycophenolate mofetil is an immunosuppressive drug that is of established efficacy in renal transplantation. It inhibits the de novo pathway of purine synthesis and therefore lymphocyte proliferation. Mycophenylate mofetil has been shown to ameliorate the severity of renal injury in murine models of lupus nephritis. Recent studies suggest that it may also be effective in the treatment of patients with lupus nephritis when used in conjunction with steroids. These observations need to be confirmed in adequately sized randomised-controlled studies.
Authors	D Adu, J Cross, D R Jayne
Journal	Lupus (Lupus) Vol. 10 Issue 3 Pg. 203-8 ( 2001) ISSN: 0961-2033 [Print] England
PMID	11315353 (Publication Type: Journal Article, Review)
Chemical References	Anti-Inflammatory Agents, Non-Steroidal Mycophenolic Acid
Topics	Animals Anti-Inflammatory Agents, Non-Steroidal (therapeutic use) Humans Lupus Erythematosus, Systemic (drug therapy) Mycophenolic Acid (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!